From: MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells
Variable
HR
Traning cohort (95% CI)
P value
Validation cohort (95% CI)
R-IPI
12.087
2.684–54.472
0.001
1.916
1.261–2.911
0.002
miR155
7.035
1.497–33.053
0.013
2.230
1.183–4.202